Albuminuria by diabetes mellitus: Marker and motor of diabetic nephropathy and vascular complications

被引:0
|
作者
Hunger-Dathe W. [1 ,2 ]
Wolf G. [1 ]
机构
[1] Klinik für Innere Medizin III, Klinikum, Friedrich-Schiller-Universität, Jena
[2] Klinik für Innere Medizin III, Klinikum, Friedrich-Schiller-Universität
来源
Der Diabetologe | 2006年 / 2卷 / 5期
关键词
Cardiovascular morbidity; Diabetic nephropathy; Microalbuminuria; Myocardial infarct; Stroke;
D O I
10.1007/s11428-006-0069-z
中图分类号
学科分类号
摘要
Diabetic nephropathy requires intensive treatment as it is the main reason for the morbidity and mortality resulting from diabetes mellitus. Patients with diabetic nephropathy have a significantly higher mortality rate due to cardiovascular events such as myocardial infarct or stroke. Microalbuminuria is the earliest clinical sign of diabetic renal disease and is also a marker for increased cardiovascular morbidity and mortality. Thus, its early detection allows not only for effective secondary prevention of the progression of diabetic nephropathy, but is also an indication for the implementation of an individually-tailored cardiovascular risk reduction management program. People with diabetes mellitus are high risk patients who need intensive monitoring and intensive supportive therapy. © Springer Medizin Verlag 2006.
引用
收藏
页码:400 / 409
页数:9
相关论文
共 50 条
  • [1] Biomarkers of Oxidative Stress in Diabetes Mellitus with Diabetic Nephropathy Complications
    Goycheva, Petya
    Petkova-Parlapanska, Kamelia
    Georgieva, Ekaterina
    Karamalakova, Yanka
    Nikolova, Galina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [2] ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM?
    Boize, R
    Benhamou, PY
    Corticelli, P
    Valenti, K
    Bosson, JL
    Halimi, S
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (01) : 72 - 75
  • [3] Clinical impact of albuminuria in diabetic nephropathy
    Wada, Takashi
    Shimizu, Miho
    Toyama, Tadashi
    Hara, Akinori
    Kaneko, Shuichi
    Furuichi, Kengo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2012, 16 (01) : 96 - 101
  • [4] Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy A Cross-Sectional Analysis of Diabetes Mellitus
    Tsai, Shang-Feng
    Su, Chien-Wei
    Wu, Ming-Ju
    Chen, Cheng-Hsu
    Fu, Chia-Po
    Liu, Chin-San
    Hsieh, Mingli
    MEDICINE, 2015, 94 (42) : e1802
  • [5] Metabolic control of insulin-dependent diabetes mellitus and diabetic nephropathy
    Olmos, MAM
    delaMorena, LH
    Vaquero, PM
    Martinez, AM
    Grande, C
    deAlvaro, F
    Dapena, F
    Pallardo, LF
    REVISTA CLINICA ESPANOLA, 1997, 197 (01): : 18 - 22
  • [6] Advances in diabetes mellitus, diabetic nephropathy, metabolic syndrome and cardio-vascular-renal risk
    Martinez Castelao, A.
    NEFROLOGIA, 2008, 28 : 79 - 84
  • [7] The oxidative stress status in diabetes mellitus and diabetic nephropathy
    Pan, Hong-zhi
    Zhang, Lin
    Guo, Mei-yi
    Sui, Hong
    Li, Hui
    Wu, Wei-hua
    Qu, Nai-qiang
    Liang, Mei-hua
    Chang, Dong
    ACTA DIABETOLOGICA, 2010, 47 : S71 - S76
  • [8] Type IV collagen as an early marker for diabetic nephropathy in non-insulin-dependent diabetes mellitus
    Kotajima, N
    Kimura, T
    Kanda, T
    Obata, K
    Kuwabara, A
    Fukumura, Y
    Kobayashi, I
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2000, 14 (01) : 13 - 17
  • [9] Haplotype analysis of the RAGE gene:: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus
    Kanková, K
    Stejskalová, A
    Hertlová, M
    Znojil, V
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (06) : 1093 - 1102
  • [10] NGAL as an Early Predictive Marker of Diabetic Nephropathy in Children and Young Adults with Type 1 Diabetes Mellitus
    Papadopoulou-Marketou, Nektaria
    Margeli, Alexandra
    Papassotiriou, Ioannis
    Chrousos, George P.
    Kanaka-Gantenbein, Christina
    Wahlberg, Jeanette
    JOURNAL OF DIABETES RESEARCH, 2017, 2017